Cargando…
Dramatic response of metaplastic breast cancer to chemo-immunotherapy
Frequent overexpression of programmed death-ligand 1 has recently been demonstrated in metaplastic breast cancer, which is a rare breast cancer subtype with limited treatment options. This report describes the clinical course of a patient with metastatic metaplastic breast cancer who had a remarkabl...
Autor principal: | Adams, Sylvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445614/ https://www.ncbi.nlm.nih.gov/pubmed/28649648 http://dx.doi.org/10.1038/s41523-017-0011-0 |
Ejemplares similares
-
Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination
por: Al Sayed, Adher D., et al.
Publicado: (2019) -
Immunotherapy Combined with Chemotherapy in Relapse Metaplastic Breast Cancer
por: Chen, Ling, et al.
Publicado: (2023) -
Induction of β-adrenergic metaplasticity of LTP requires intact anchoring of PKA
por: Hoffman, Janlyn R., et al.
Publicado: (2019) -
Cancer Immunotherapy Trials Underutilize Immune Response Monitoring
por: Connell, Claire M., et al.
Publicado: (2017) -
Metaplastic Breast Cancer: To Radiate or Not to Radiate?
por: Tseng, Warren H., et al.
Publicado: (2010)